Atrium Health Cleveland/LCI-Cleveland — Shelby, North Carolina

Atrium Health Cleveland/LCI-Cleveland is a clinical research site located in Shelby, North Carolina, United States 28150.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Atrium Health Cleveland/LCI-Cleveland has participated in 30 clinical trials with 20 currently active.

Therapeutic areas: Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Ductal Carcinoma In Situ.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Shelby

Browse all research sites in North Carolina · View every site in Shelby

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atrium Health Cleveland/LCI-Cleveland?

Atrium Health Cleveland/LCI-Cleveland has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atrium Health Cleveland/LCI-Cleveland conducted?

Atrium Health Cleveland/LCI-Cleveland has 30 clinical trials on record, with 20 currently active. Their work covers Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Ductal Carcinoma In Situ.

Is Atrium Health Cleveland/LCI-Cleveland accredited by Crixeo Clinical Trials?

Atrium Health Cleveland/LCI-Cleveland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atrium Health Cleveland/LCI-Cleveland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.